The signs that matter clinically are carpal-tunnel-like wrist symptoms, persistent joint pain, or elevated blood glucose, these usually indicate IGF-1 is too high and dosing needs to be reduced
Weight loss results from clinical trials: Adults lost nearly 15% of their starting body weight on average Adolescents lost almost 15% of their starting body weight Wegovy HD (higher dose) produced 19% average weight loss Cardiovascular benefit: The SELECT trial showed a 20% reduction in MACE risk compared to placebo
Right-upper-quadrant pain , especially if accompanied by fever or yellowing of the skin/eyes (jaundice), requires urgent assessment, as GLP-1 medications and weight loss can increase the risk of gallbladder disease
( 10.1007/s12325-023-02750-4) [DOI] [PMC free article] [PubMed] [Google Scholar] Ferdinand KC White WB Calhoun DA Lonn EM Sager PT Brunelle R Jiang HH Threlkeld RJ Robertson KE & Geiger MJ
Youll have continued support for dose adjustments, side-effect monitoring, and guidance on nutrition, movement, and long-term maintenance
